RecruitingNCT07178886

Breast Reconstruction and Radiotherapy

Breast Reconstruction and Radiotherapy: a Nationwide Cohort Study on Care Evaluation and Optimization


Sponsor

Janine M. Simons MD PhD

Enrollment

750 participants

Start Date

Aug 22, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

If the whole breast is removed because of breast cancer, several options for breast reconstruction are available. All these options have an increased complication risk if a patient has been or will be treated with radiotherapy. However, only a few high-quality studies addressed patient satisfaction and complication risks, both in terms of timing (prior to or after irradiation) and type of reconstruction (implant or own tissue). As radiotherapy indications expand and more patients desire a reconstruction, this is a progressively relevant issue. Through this nationwide prospective study, the investigators aim to identify the most ideal treatment strategy by comparing different reconstruction options in terms of patient reported outcomes (PROs), toxicity, oncological safety and costs. These results will enable improvement of shared decision-making and cost-effectiveness of breast reconstruction strategies in case of radiotherapy.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • years of age or older
  • Diagnosed with unilateral non-metastatic breast cancer
  • (to be) Treated with mastectomy and to be treated with adjuvant radiotherapy
  • Willing and able to provide written informed consent

Exclusion Criteria3

  • History of DCIS or invasive breast cancer
  • Previous thoracic radiotherapy treatment
  • History of other malignancies (except for patients with basal or squamous cell skin cancer, in situ carcinoma of the cervix and patients who are disease-free at least 5 years following successful treatment for other malignancies)

Locations(1)

Erasmus Medical Center

Rotterdam, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07178886


Related Trials